Process for producing molecules containing specialized glycan structures
Inventors
Sandig, Volker • Von Horsten, Hans Henning • Ogorek, Christiane
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
The present invention relates to cells for producing a molecule lacking fucose, having a reduced amount of fucose, or having other atypical sugars on its glycomoieties. It also relates to methods for producing a molecule lacking fucose, having a reduced amount of fucose, or having other atypical sugars on its glycomoieties using said cells and to molecules obtainable by said methods. The present invention further relates to molecules having an artificial glycosylation pattern.
Core Innovation
The invention concerns a glycoengineering strategy for producing a protein molecule that lacks fucose or has a reduced amount of fucose on its glycomoieties. It provides recombinant vertebrate and eukaryotic producer cells engineered for altered nucleotide-sugar processing and configured to use GDP-6-deoxy-D-lyxo-4-hexylose as a substrate while preventing its conversion into GDP-L-fucose.
In particular, the recombinant vertebrate cell includes a polynucleotide that encodes at least one GDP-6-deoxy-D-lyxo-4-hexylose-utilizing enzyme, where the enzyme does not catalyze the reaction converting GDP-6-deoxy-D-lyxo-4-hexylose into GDP-L-fucose. The described scope includes specific enzymes associated with GDP-6-deoxy-D-lyxo-4-hexulose, including RMD, Per, GTS, and variants such as GFS-Cys109Ser, as well as deflecting enzymes such as ColD together with GDP-L-colitose synthase (ColC).
The disclosed invention also extends to an expression unit and to recombinant eukaryotic cells using first and second polynucleotides, where the encoded enzyme does not catalyze GDP-6-deoxy-D-lyxo-4-hexylose-to-GDP-L-fucose conversion. Proteins and compositions produced by the engineered cells are described as having fucose deficiency or reduced fucose, with embodiments that include artificial sugar incorporation and compositions or protein products having a defined glycosylation pattern.
Claims Coverage
The partial content identifies three independent claims. Across these claims, the coverage centers on recombinant vertebrate and eukaryotic producer cells engineered to prevent GDP-6-deoxy-D-lyxo-4-hexylose conversion into GDP-L-fucose, and on an expression unit encoding the relevant GDP-6-deoxy-D-lyxo-4-hexylose substrate-using enzyme.
Recombinant vertebrate cell with GDP-6-deoxy-D-lyxo-4-hexylose-utilizing enzyme not converting to GDP-L-fucose
A recombinant vertebrate cell for producing a protein molecule lacking fucose or having a reduced amount of fucose on its glycomoieties, comprising a polynucleotide that encodes at least one enzyme which uses GDP-6-deoxy-D-lyxo-4-hexylose as a substrate, wherein the enzyme does not catalyze the reaction which converts GDP-6-deoxy-D-lyxo-4-hexylose into GDP-L-fucose.
Expression unit encoding non-GDP-L-fucose-converting GDP-6-deoxy-D-lyxo-4-hexylose substrate enzyme
An expression unit comprising one or more vertebrate expression control sequences operably linked to a polynucleotide comprising a nucleic acid sequence encoding an enzyme which uses GDP-6-deoxy-D-lyxo-4-hexylose as a substrate, wherein the enzyme does not catalyze the reaction which converts GDP-6-deoxy-D-lyxo-4-hexylose into GDP-L-fucose.
Recombinant eukaryotic cell with first and second polynucleotides enforcing reduced or no fucose via non-converting GDP-6-deoxy-D-lyxo-4-hexylose enzyme
A recombinant eukaryotic cell for producing a protein, lacking fucose or with a reduced amount of fucose on its glycomoieties comprising a first polynucleotide encoding an enzyme which uses GDP-6-deoxy-D-lyxo-4-hexylose as a substrate and a second polynucleotide encoding a protein, wherein the enzyme does not catalyze the reaction which converts GDP-6-deoxy-D-lyxo-4-hexylose into GDP-L-fucose.
Together, the independent claims cover engineered vertebrate and eukaryotic cells and an expression unit that include a GDP-6-deoxy-D-lyxo-4-hexylose substrate-using enzyme that does not catalyze conversion into GDP-L-fucose, thereby enabling production of proteins lacking fucose or with reduced fucose on glycomoieties.
Stated Advantages
Enhanced FcγRIIIa binding.
Enhanced ADCC activity.
Reduced core-fucosylation effects by producing fucose-deficient or reduced-fucose proteins.
Documented Applications
Therapeutic proteins where increased FcγRIIIa binding and enhanced ADCC are relevant, including an IgG therapeutic context with Trastuzumab (Herceptin).
A viral vaccine context is mentioned as an example protein payload.
Production of defensins or cationic peptides is mentioned as an example protein payload.
Interested in licensing this patent?